September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 11, 2025

Medical Oddities: The Metabolic Recipe for Sleepiness

Science this week serves up naps, plaque stealth, binge boosts, tea twists, and brain maps.

Conexiant

September 09, 2025

Dietary Nitrate Lowers Blood Pressure in Older Adults, Study

Researchers show nitrate-rich beetroot reshapes the oral microbiome.

Conexiant

September 09, 2025

Gastrointestinal Disorders Linked to Sleep Problems

Study of more than 10,000 US adults finds depression accounts for 21% of the relationship between stomach illness and sleep disturbances, suggesting need for integrated treatment approaches

Conexiant

September 05, 2025

Stroke Odds Climb With Lower LE8 Scores

Modifiable lifestyle factors missing from risk prediction equations can be assessed with Life’s Essentials 8.

Conexiant

September 04, 2025

Persistent Grief Symptoms and Higher Mortality

Grief symptom trajectories serve as early indicators of future health care use, psychotropic medication needs, and mortality risk in bereaved individuals.

Conexiant

September 04, 2025

Less TV Time May Lower Depression Risk

Compositional data analysis reveals age-specific benefits of reallocating TV-watching time to other activities, including physical activity and sleep.

Conexiant

August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant